Haploidentical Hematopoietic Stem Cell Transplant For Sickle Cell Disease Using Thiotepa Based Reduced Intensity Conditioning And Post Transplant Cyclophosphamide

被引：0
|
作者：
Kharya, D. G. [1 ]
Doval, D. [1 ]
Chaudhary, D. R. [1 ]
Dhamija, M. [1 ]
Khandelwal, V. [1 ]
Lunkad, S. [1 ]
Setia, R. [1 ]
Handoo, A. [1 ]
Sharma, S. [1 ]
Dadu, T. [1 ]
机构：
[1] BLK Super Special Hosp, Delhi, India
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
AB009
引用
收藏
页码：5556 / 5557
页数：2
相关论文
共 50 条
  • [21] HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR PEDIATRIC SICKLE CELL DISEASE WITHIN THE POST-TRANSPLANT CYCLOPHOSPHAMIDE ERA
    Oostenbrink, Lisa
    Smiers, Frans
    Jansen-Hoogendijk, Anja
    Schilham, Marco
    Lankester, Arjan
    Mohseny, Alexander
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 385 - 386
  • [22] Haploidentical Hematopoietic Stem Cell Transplantation Followed by ‘Post-Cyclophosphamide’: The Future of Allogeneic Stem Cell Transplant
    Samuel Cytryn
    Maher Abdul-Hay
    Clinical Hematology International, 2020, 2 (2) : 49 - 58
  • [23] SAFETY OF T-CELL REPLETE HAPLOIDENTICAL STEM CELL TRANSPLANTATION USING FLUDARABINE, MELPAHALAN AND THIOTEPA CONDITIONING AND HIGH-DOSE POST-TRANSPLANT CYCLOPHOSPHAMIDE
    Ciurea, S. O.
    de Lima, M.
    Kebriaei, P.
    Rondon, G.
    Saliba, R.
    McMannis, J.
    Andersson, B. S.
    Khouri, I. F.
    Giralt, S.
    Champlin, R. E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2010, 16 (02) : S218 - S218
  • [24] Hematopoietic Stem Cell Transplant (HSCT) Utilizing Reduced Intensity Conditioning without Radiation Is an Effective Treatment for Children with Sickle Cell Disease Using Alternative Donors
    Rumelhart, Stephen
    Cleppe, Jason
    Amelon, Elizabeth
    McCue, Paula
    Sharathkumar, Anjali
    Rokes, Christopher
    Modi, Arunkumar
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S213 - S213
  • [25] Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Severe Aplastic Anemia
    Bonfim, Carmem
    Arcuri, Leonardo Javier
    Nabhan, Samir
    Seber, Adriana
    Nichele, Samantha
    Moreira Funke, Vaneuza Araujo
    Fernandes, Juliana Folloni
    Daudt, Liane Esteves
    Darrigo, Luiz Guilherme, Jr.
    Melo Rodrigues, Ana Luiza
    Guerino Cunha, Renato Luiz
    Arrais, Celso
    Ribeiro, Andreza Feitosa
    Atta, Elias
    Rodrigues Oliveira, Jose Salvador
    Paz, Alessandra
    Calixto, Rodolfo Froes
    Gomes, Alessandra
    Sa Araujo, Carlos Eduardo
    Colturato, Vergilio A. R., Sr.
    Flowers, Mary E. D.
    Pasquini, Ricardo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S252 - S252
  • [26] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis
    Diego Medina-Valencia
    Daniela Cleves
    Estefania Beltran
    Natalia Builes
    Alexis A. Franco
    Andrés Felipe Escobar-González
    Manuela Olaya
    Journal of Clinical Immunology, 2021, 41 : 1172 - 1177
  • [27] Haploidentical Stem Cell Transplant with Post-Transplant Cyclophosphamide in Pediatric Hemophagocytic Lymphohistiocytosis
    Medina-Valencia, Diego
    Cleves, Daniela
    Beltran, Estefania
    Builes, Natalia
    Franco, Alexis A.
    Felipe Escobar-Gonzalez, Andres
    Olaya, Manuela
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1172 - 1177
  • [28] Cerebral hemodynamic changes after haploidentical hematopoietic stem cell transplant in adults with sickle cell disease
    Aumann, Megan A.
    Richerson, Wesley
    Song, Alexander K.
    Davis, L. Taylor
    Pruthi, Sumit
    Davis, Samantha
    Patel, Niral J.
    Custer, Chelsea
    Kassim, Adetola A.
    Debaun, Michael R.
    Donahue, Manus J.
    Jordan, Lori C.
    BLOOD ADVANCES, 2024, 8 (03) : 608 - 619
  • [29] Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
    Mohty, Razan
    Al Kadhimi, Zaid
    Kharfan-Dabaja, Mohamed
    HEMATOLOGY, 2024, 29 (01)
  • [30] HAPLOIDENTICAL RELATED DONOR PERIPHERAL BLOOD STEM CELL TRANSPLANT FOR THALASSEMIA MAJOR WITH POST TRANSLANT CYCLOPHOSPHAMIDE AND THIOTEPA, FLUADARABNE AND TREOSULFAN OR BUSULFAN CONDITIONING
    Yadav, Satya Prakash
    Thakkar, Dhwanee
    Upasana, K.
    Arora, Sunisha
    Khandewal, Rachit
    Rastogi, Neha
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 389 - 390
12345